Chemical Name:2-hydroxy-5-methoxybenzamide

CAS.NO:28534-37-4

Synonyms:5-Methoxysalicylamid;Benzamide,2-hydroxy-5-methoxy;2-hydroxy-5-methoxy-benzamide;5-methoxysalicylamide;Salicylamide,5-methoxy;2-Hydroxy-5-methoxy-benzoesaeure-amid

Molecular Formula:C₈H₉NO₃

Molecular Weight:167.16200

HS Code:2924299090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:320.5ºC at 760 mmHg

Density:1.28 g/cm3

Index of Refraction:1.584

PSA:72.55000

Exact Mass:167.05800

LogP:1.20000

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 5-Methoxysalicylamid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Hydroxy-5-methoxy-benzoesaeure-amid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Salicylamide,5-methoxy Use and application,2-Hydroxy-5-methoxy-benzoesaeure-amid technical grade,usp/ep/jp grade.

Related News: CROS NT built up its own biometric services portfolio: clinical data management, biostatistics, statistical programming and medical writing, through a series of acquisitions in the early 2010s. In 2013, CROS NT established a foothold in the U.S. with its purchase of Stat-Tech Services, which had a presence in the medical devices sector. CROS NT followed up the next year with its buy of biometrics services provider MDSL International to broaden its U.K. branch. 2-hydroxy-5-methoxybenzamide manufacturer With the advancement of supply-side structural reforms, the production of bulk APIs in China will become more concentrated, and the technology will be further improved. 2-hydroxy-5-methoxybenzamide supplier With the advancement of supply-side structural reforms, the production of bulk APIs in China will become more concentrated, and the technology will be further improved. 2-hydroxy-5-methoxybenzamide vendor As part of the agreement, ICIG will enter into a 5-year supply contract to provide Genzyme with materials needed for the production of eliglustat tartrate, an investigational treatment for Gaucher disease Type 1 that is currently in Phase III clinical trials. 2-hydroxy-5-methoxybenzamide factory Also, states with higher obesity rates also tend to have higher rates of food insecurity, which means lower incomes in general,” she noted. “Bariatric surgery is an expensive proposition, especially if one does not have good insurance coverage for it.